Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rachel Campbell, Madeleine T King, Martin R Stockler, Yeh Chen Lee, Felicia T Roncolato & Michael L Friedlander. (2023) Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice. Patient Related Outcome Measures 14, pages 111-126.
Read now
Read now
Sharolin Boban, Jenny Downs, Jim Codde, Paul A Cohen & Caroline Bulsara. (2021) Women Diagnosed with Ovarian Cancer: Patient and Carer Experiences and Perspectives. Patient Related Outcome Measures 12, pages 33-43.
Read now
Read now
Costanza Puppo, Lolane Dentand, Olivier Tredan, Djihane Ahmed-Lecheheb, Florence Joly & Marie Préau. (2020) The quality of life of long-term remission patients in the Vivrovaire study: The impact of ovarian cancer on patient trajectory. Journal of Psychosocial Oncology 38:4, pages 481-500.
Read now
Read now
Sung Reul Kim, Ju-Hee Nho & Joo-Hyun Nam. (2018) Relationships among Type-D personality, symptoms and quality of life in patients with ovarian cancer receiving chemotherapy. Journal of Psychosomatic Obstetrics & Gynecology 39:4, pages 289-296.
Read now
Read now
Dana M Chase, Lari B Wenzel & Bradley J Monk. (2012) Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 279-281.
Read now
Read now
Articles from other publishers (23)
Ruby M. van Stein, Florine J. Hendriks, Valesca P. Retèl, Cor D. de Kroon, Christianne A.R. Lok, Gabe S. Sonke, Kelly M. de Ligt & Willemien J. van Driel. (2023) Health state utility and health-related quality of life measures in patients with advanced ovarian cancer. Gynecologic Oncology Reports 50, pages 101293.
Crossref
Crossref
Husnu Tore Yavuzsen, Sukriye Cansu Gulteki̇n, Karya Polat, Murat Keser, Zeynep Gulsum Guc, Merve Keskinkilic, Tugba Yavuzsen & Didem Karadibak. (2023) Validity and Reliability of the Turkish Version of National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Ovarian Symptom Index-18 (NFOSI-18) and Neurotoxicity-4 (NTX-4) for Patients with Advanced Ovarian Cancer. European Journal of Cancer Care 2023, pages 1-8.
Crossref
Crossref
Siqi Hu, David Baraghoshi, Chun‐Pin Chang, Kerry Rowe, John Snyder, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken Smith, Anita R. Peoples, David Gaffney & Mia Hashibe. (2022) Mental health disorders among ovarian cancer survivors in a population‐based cohort. Cancer Medicine 12:2, pages 1801-1812.
Crossref
Crossref
Dana M. Chase, Margarita Romeo Marín, Floor Backes, Sileny Han, Whitney Graybill, Mansoor Raza Mirza, Bhavana Pothuri, Giorgia Mangili, David M. O'Malley, Dominique Berton, Lyndsay Willmott, Klaus Baumann, Robert L. Coleman, Tamar Safra, Viola Heinzelmann-Schwarz, Domenica Lorusso, Florian M. Karl, Tatia Woodward, Bradley J. Monk & Antonio Gonzalez-Martin. (2022) Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial. Gynecologic Oncology 166:3, pages 494-502.
Crossref
Crossref
Vasilios Pergialiotis, Ioanna Myrto Sotiropoulou, Efstathia Liatsou, Michalis Liontos, Maximos Frountzas, Nikolaos Thomakos, Alexandros Rodolakis & Dimitrios Haidopoulos. (2022) Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature. Supportive Care in Cancer 30:9, pages 7147-7157.
Crossref
Crossref
Sinjini Sarkar, Pranab K. Sahoo, Ranita Pal, Tanuma Mistry, Sutapa Mahata, Puja Chatterjee, Manisha Vernekar, Syamsundar Mandal, Tanmoy Bera & Vilas D. Nasare. (2022) Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India. Supportive Care in Cancer 30:4, pages 3371-3378.
Crossref
Crossref
Sarah M. Temkin, Matthew P. Smeltzer, Monique D. Dawkins, Leigh M. Boehmer, Leigha Senter, Destin R. Black, Stephanie V. Blank, Anna Yemelyanova, Anthony M. Magliocco, Mollie A. Finkel, Tracy E. Moore & Premal H. Thaker. (2021) Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations. Cancer 128:4, pages 654-664.
Crossref
Crossref
Joseph J. Noh & Yoo-Young Lee. (2022) Where is ERAS in the management of advanced ovarian cancer?: between myths and truths. Journal of Gynecologic Oncology 33:5.
Crossref
Crossref
Rachel Campbell, Madeleine T. King, Yeh Chen Lee, Linda Mileshkin, Margaret-Ann Tait & Claudia Rutherford. 2022. Advances in Diagnosis and Management of Ovarian Cancer. Advances in Diagnosis and Management of Ovarian Cancer
225
241
.
Amanda Canato Ferracini, Gabriela Pereira, Cinthia Madeira de Souza, Thiago Fortes Cabello dos Santos, Luís Otávio Sarian, Sophie Derchain & Priscila Gava Mazzola. (2021) Physical and functional well-being and symptoms of ovarian cancer in women undergoing first-line of chemotherapy: a one-year follow-up. Supportive Care in Cancer 29:12, pages 7421-7430.
Crossref
Crossref
Ana Oaknin, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García‐Donas, Elizabeth M. Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A. Ledermann & Robert L. Coleman. (2021) Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety. Cancer Medicine 10:20, pages 7162-7173.
Crossref
Crossref
Radu Dragomir, Ioan Sas, Sorin Săftescu, Dorel Popovici, Roxana Margan, Adelina Silvana Dragomir, Horia Stanca, Valeria Mocanu, Cristina Pac & Șerban Negru. (2021) Treatment Experience and Predictive Factors Associated with Response in Platinum-Resistant Recurrent Ovarian Cancer: A Retrospective Single-Institution Study. Journal of Clinical Medicine 10:16, pages 3596.
Crossref
Crossref
Andrew R Clamp, Domenica Lorusso, Amit M Oza, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O’Malley, Deborah K Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M Swisher, Terri Cameron, Sandra Goble, Robert L Coleman & Jonathan A Ledermann. (2021) Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3. International Journal of Gynecologic Cancer 31:7, pages 949-958.
Crossref
Crossref
Michael Friedlander, Kathleen N Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Alla Lisyanskaya, Gabe S Sonke, Charlie Gourley, Susana Banerjee, Amit Oza, Antonio González-Martín, Carol Aghajanian, William H Bradley, Joyce Liu, Cara Mathews, Frédéric Selle, Alain Lortholary, Elizabeth S Lowe, Robert Hettle, Emuella Flood, Elena Parkhomenko & Paul DiSilvestro. (2021) Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial. The Lancet Oncology 22:5, pages 632-642.
Crossref
Crossref
Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M. Swisher, David Cella, Juliette Meunier, Sandra Goble, Terri Cameron, Lara Maloney, Ann-Christin Mörk, Josh Bedel, Jonathan A. Ledermann & Robert L. Coleman. (2020) Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. Journal of Clinical Oncology 38:30, pages 3494-3505.
Crossref
Crossref
Anette Stolberg Kargo, Angela Coulter, Pernille Tine Jensen & Karina Dahl Steffensen. (2019) Proactive use of PROMs in ovarian cancer survivors: a systematic review. Journal of Ovarian Research 12:1.
Crossref
Crossref
Esra Urkmez, Elif Andac-Jones, David Cibula, Denis Querleu, Michael J Halaska, Daniel Driak, Jalid Sehouli, Jacek P Grabowski, Gulhan Inci, Kamil Zalewski, Lucas Minig, Cristina Zorrero, Muzaffer Sancı, Murat Alan, Jonathan A Ledermann, Christina Fotopoulou & Murat Gultekin. (2019) Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey. International Journal of Gynecologic Cancer 29:9, pages 1425-1430.
Crossref
Crossref
Renata Raś, Edyta Barnaś, Joanna Skręt- Magierło, Anna Drozdzowska, Ewelina Bartosiewicz, Marek Sobolewski, Andrzej Skręt & Krzysztof Gutkowski. (2019) Preoperative colonoscopy in patients with a supposed primary ovarian cancer. Medicine 98:12, pages e14929.
Crossref
Crossref
Sally E. Jensen & David Cella. 2014. Advances in Diagnosis and Management of Ovarian Cancer. Advances in Diagnosis and Management of Ovarian Cancer
241
260
.
Silvana Canevari, Francesco Raspagliesi & Domenica Lorusso. (2013) Bevacizumab treatment and quality of life in advanced ovarian cancer. Future Oncology 9:7, pages 951-954.
Crossref
Crossref
Dan Stark, Matthew Nankivell, Eric Pujade-Lauraine, Gunnar Kristensen, Lorraine Elit, Martin Stockler, Felix Hilpert, Andrés Cervantes, Julia Brown, Anne Lanceley, Galina Velikova, Eduardo Sabate, Jacobus Pfisterer, Mark S Carey, Philip Beale, Wendi Qian, Ann Marie Swart, Amit Oza & Tim Perren. (2013) Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. The Lancet Oncology 14:3, pages 236-243.
Crossref
Crossref
Lisa M. Hess & Frederick B. Stehman. (2012) State of the Science in Ovarian Cancer Quality of Life Research: A Systematic Review. International Journal of Gynecologic Cancer 22:7, pages 1273-1280.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:5, pages 587-595.
Crossref
Crossref